These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 21835135)

  • 41. No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.
    Oldhoff JM; Darsow U; Werfel T; Bihari IC; Katzer K; Laifaoui J; Plötz S; Kapp A; Knol EF; Bruijnzeel-Koomen CA; Ring J; de Bruin-Weller MS
    Int Arch Allergy Immunol; 2006; 141(3):290-4. PubMed ID: 16931891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
    Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
    Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis.
    Chehade M; Sampson HA; Morotti RA; Magid MS
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):319-28. PubMed ID: 17873744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
    Ortega HG; Yancey SW; Mayer B; Gunsoy NB; Keene ON; Bleecker ER; Brightling CE; Pavord ID
    Lancet Respir Med; 2016 Jul; 4(7):549-556. PubMed ID: 27177493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis.
    Alexander JA; Jung KW; Arora AS; Enders F; Katzka DA; Kephardt GM; Kita H; Kryzer LA; Romero Y; Smyrk TC; Talley NJ
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):742-749.e1. PubMed ID: 22475741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?
    Ko E; Chehade M
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):205-216. PubMed ID: 29372536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
    Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
    J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eosinophilic Esophagitis and Esophageal Granular Cell Tumor: An Unexpected Association.
    Riffle ME; Polydorides AD; Niakan J; Chehade M
    Am J Surg Pathol; 2017 May; 41(5):616-621. PubMed ID: 28296675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood tests and histological correlates in children with eosinophilic oesophagitis.
    Marlais M; Francis ND; Fell JM; Rawat DJ
    Acta Paediatr; 2011 Aug; 100(8):e75-9. PubMed ID: 21352358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of esophageal eosinophils in patients with Barrett's esophagus.
    Ravi K; Katzka DA; Smyrk TC; Prasad GA; Romero Y; Francis DL; Lutzke L; Tian J; Wang KK
    Am J Gastroenterol; 2011 May; 106(5):851-7. PubMed ID: 21304498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.
    Bolton SM; Kagalwalla AF; Arva NC; Wang MY; Amsden K; Melin-Aldana H; Dellon ES; Bryce PJ; Wershil BK; Wechsler JB
    Am J Gastroenterol; 2020 Feb; 115(2):224-233. PubMed ID: 31913192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of Epicutaneous Immunotherapy in Children With Milk-Induced Eosinophilic Esophagitis.
    Spergel JM; Elci OU; Muir AB; Liacouras CA; Wilkins BJ; Burke D; Lewis MO; Brown-Whitehorn T; Cianferoni A
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):328-336.e7. PubMed ID: 31100455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathology of eosinophilic esophagitis: what the clinician needs to know.
    Odze RD
    Am J Gastroenterol; 2009 Feb; 104(2):485-90. PubMed ID: 19174804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.
    Rothenberg ME; Wen T; Greenberg A; Alpan O; Enav B; Hirano I; Nadeau K; Kaiser S; Peters T; Perez A; Jones I; Arm JP; Strieter RM; Sabo R; Gunawardena KA
    J Allergy Clin Immunol; 2015 Feb; 135(2):500-7. PubMed ID: 25226850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eosinophil counts in upper digestive mucosa of Western European children: variations with age, organs, symptoms, Helicobacter pylori status, and pathological findings.
    Kalach N; Huvenne H; Gosset P; Papadopoulos S; Dehecq E; Decoster A; Creusy C; Dupont C
    J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):175-82. PubMed ID: 20890222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reflectance confocal microscopy for the diagnosis of eosinophilic esophagitis: a pilot study conducted on biopsy specimens.
    Yoo H; Kang D; Katz AJ; Lauwers GY; Nishioka NS; Yagi Y; Tanpowpong P; Namati J; Bouma BE; Tearney GJ
    Gastrointest Endosc; 2011 Nov; 74(5):992-1000. PubMed ID: 21944314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of esophageal eosinophil counts and other histologic features of eosinophilic esophagitis by pathology trainees is highly accurate.
    Rusin S; Covey S; Perjar I; Hollyfield J; Speck O; Woodward K; Woosley JT; Dellon ES
    Hum Pathol; 2017 Apr; 62():50-55. PubMed ID: 28041975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.